Stockreport

Purple Biotech Reaches Recommended Phase 2 Dose for NT219 [Yahoo! Finance]

Purple Biotech Ltd. - American Depositary Shares  (PPBT) 
PDF company developing first-in-class therapies that harness the power of the tumor microenvironment to overcome tumor immune evasion and drug resistance, today announced it [Read more]